Social pharmaceutical innovation and alternative forms of research, development and deployment for drugs for rare diseases

Rare diseases are associated with difficulties in addressing unmet medical needs, lack of access to treatment, high prices, evidentiary mismatch, equity, etc. While challenges facing the development of drugs for rare diseases are experienced differently globally (i.e., higher vs. lower and middle in...

Descripción completa

Detalles Bibliográficos
Autores principales: Douglas, Conor M. W., Aith, Fernando, Boon, Wouter, de Neiva Borba, Marina, Doganova, Liliana, Grunebaum, Shir, Hagendijk, Rob, Lynd, Larry, Mallard, Alexandre, Mohamed, Faisal Ali, Moors, Ellen, Oliveira, Claudio Cordovil, Paterson, Florence, Scanga, Vanessa, Soares, Julino, Raberharisoa, Vololona, Kleinhout-Vliek, Tineke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Position Statement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446828/
https://www.ncbi.nlm.nih.gov/pubmed/36064440
http://dx.doi.org/10.1186/s13023-022-02476-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446828/
https://www.ncbi.nlm.nih.gov/pubmed/36064440
http://dx.doi.org/10.1186/s13023-022-02476-6

Ejemplares similares